The pancreas secretes glucagon to help maintain blood sugar levels, affecting hunger and satiety signals
Intended Use: For Laboratory Research Use Only Key Characteristics of Semaglutide (5 mg) Synthetic GLP-1 receptor agonist analog designed for research use Modified structure for enhanced stability in experimental systems Fatty acid side chain supports prolonged receptor interaction in laboratory models High analytical purity verified by HPLC and mass spectrometry Supplied as a lyophilized powder to preserve peptide integrity prior to reconstitution Suitable for endocrine, metabolic, and receptor-signaling research Compatible with standard peptide reconstitution and handling procedures How Semaglutide (5 mg) Supports Research Semaglutide (5 mg) is used in research to study GLP-1 receptor signaling and its effects on metabolic pathways
This once-daily pill contains 25 mg of semaglutide, the same active ingredient found in the weekly Wegovy injection, and works by mimicking the GLP-1 hormone to suppress appetite and regulate blood sugar
Now that the FDA declared the semaglutide shortage over, and given pharmacies a deadline to stop producing it, compounded semaglutide many not be widely available after May 2025
Using such medication may result in inadequate glycaemic control in patients with type 2 diabetes or reduced efficacy for weight management indications
Not planning for low-appetite days: Keep Cycle Cs egg white muffins and Greek yogurt bowls on rotation for days when eating a full meal feels impossible